Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Simulations Plus, Inc. (SLP)

    Price:

    16.50 USD

    ( - -0.05 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    SLP
    Name
    Simulations Plus, Inc.
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare
    Price
    16.500
    Market Cap
    332.097M
    Enterprise value
    715.224M
    Currency
    USD
    Ceo
    John Anthony DiBella
    Full Time Employees
    243
    Ipo Date
    1997-06-18
    City
    Lancaster
    Address
    42505 Tenth Street West

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Privia Health Group, Inc.

    VALUE SCORE:

    8

    Symbol
    PRVA
    Market Cap
    2.938B
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare

    2nd position

    HealthEquity, Inc.

    VALUE SCORE:

    8

    Symbol
    HQY
    Market Cap
    7.689B
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare

    The best

    Progyny, Inc.

    VALUE SCORE:

    9

    Symbol
    PGNY
    Market Cap
    1.716B
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -5.248
    P/S
    4.131
    P/B
    2.681
    Debt/Equity
    0.006
    EV/FCF
    23.472
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    3.805
    Earnings yield
    -0.191
    Debt/assets
    0.005
    FUNDAMENTALS
    Net debt/ebidta
    0.385
    Interest coverage
    0
    Research And Developement To Revenue
    0.089
    Intangile to total assets
    0.416
    Capex to operating cash flow
    0.083
    Capex to revenue
    0.015
    Capex to depreciation
    0.129
    Return on tangible assets
    -0.806
    Debt to market cap
    0.002
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    0.005
    P/CF
    23.366
    P/FCF
    25.485
    RoA %
    -47.065
    RoIC %
    -53.053
    Gross Profit Margin %
    53.745
    Quick Ratio
    5.111
    Current Ratio
    5.111
    Net Profit Margin %
    -78.670
    Net-Net
    1.440
    FUNDAMENTALS PER SHARE
    FCF per share
    0.648
    Revenue per share
    3.997
    Net income per share
    -3.144
    Operating cash flow per share
    0.706
    Free cash flow per share
    0.648
    Cash per share
    1.415
    Book value per share
    6.154
    Tangible book value per share
    3.377
    Shareholders equity per share
    6.154
    Interest debt per share
    0.036
    TECHNICAL
    52 weeks high
    37.670
    52 weeks low
    12.390
    Current trading session High
    16.770
    Current trading session Low
    16.210
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    -1.90%
    Years of div. Increase
    1.000
    Years of div.
    13.000
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    260.520
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0.004489796%
    Payout Ratio
    17.669043000000002%
    P/E
    40.265
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.008760807%
    Payout Ratio
    34.453996999999994%
    P/E
    41.638
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0.03990025%
    Payout Ratio
    62.384963000000006%
    P/E
    15.203
    logo

    Country
    IL
    Sector
    Technology
    Industry
    Software - Application
    Dividend yield
    0.015339562%
    Payout Ratio
    78.27394%
    P/E
    35.177
    logo

    Country
    US
    Sector
    Technology
    Industry
    Software - Infrastructure
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    48.008
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -13.753
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -23.600
    logo

    Country
    US
    Sector
    Communication Services
    Industry
    Internet Content & Information
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.420
    DESCRIPTION

    Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

    NEWS
    https://images.financialmodelingprep.com/news/slp-fraud-notice-simulations-plus-inc-hit-with-securities-20251008.png
    SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses

    globenewswire.com

    2025-10-08 07:36:00

    NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws. If you invested in Simulations Plus, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/simulations-plus-inc-class-action-lawsuit.

    https://images.financialmodelingprep.com/news/slp-investor-news-if-you-have-suffered-losses-in-20251006.jpeg
    SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

    globenewswire.com

    2025-10-06 20:21:00

    NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

    https://images.financialmodelingprep.com/news/slp-shareholder-notice-simulations-plus-inc-investigated-for-securities-20251006.jpg
    SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law

    globenewswire.com

    2025-10-06 08:36:00

    NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws. If you invested in Simulations Plus, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/simulations-plus-inc-class-action-lawsuit.

    https://images.financialmodelingprep.com/news/rosen-law-firm-encourages-simulations-plus-inc-investors-to-20251006.jpg
    Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

    prnewswire.com

    2025-10-06 01:24:00

    NEW YORK , Oct. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public. So What: If you purchased Simulations Plus securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

    https://images.financialmodelingprep.com/news/slp-investor-news-if-you-have-suffered-losses-in-20251003.jpeg
    SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

    globenewswire.com

    2025-10-03 19:03:00

    NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

    https://images.financialmodelingprep.com/news/simulations-plus-investigation-alert-bragar-eagel-squire-pc-reminds-20251003.jpeg
    SIMULATIONS PLUS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of Investigation into Simulations Plus, Inc. and Encourages Investors to Contact the Firm

    globenewswire.com

    2025-10-03 07:42:00

    Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Simulations Plus (SLP) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Simulations Plus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

    https://images.financialmodelingprep.com/news/johnson-fistel-investigates-simulations-plus-following-reports-of-financial-20251001.jpeg
    Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues

    globenewswire.com

    2025-10-01 17:30:00

    SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP) regarding possible violations of federal securities laws. Investors who purchased Simulations Plus securities may be eligible to recover losses stemming from alleged misrepresentations and omissions made by the company and its executives.

    https://images.financialmodelingprep.com/news/slp-investor-news-if-you-have-suffered-losses-in-simulations-20250930.jpeg
    SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

    globenewswire.com

    2025-09-30 17:40:00

    NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

    https://images.financialmodelingprep.com/news/rosen-law-firm-encourages-simulations-plus-inc-investors-to-20250929.jpg
    Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

    prnewswire.com

    2025-09-29 22:02:00

    NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

    https://images.financialmodelingprep.com/news/slp-investor-news-if-you-have-suffered-losses-in-20250926.jpeg
    SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

    globenewswire.com

    2025-09-26 18:48:00

    NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

    https://images.financialmodelingprep.com/news/slp-shareholder-alert-simulations-plus-inc-investors-may-have-20250926.png
    SLP SHAREHOLDER ALERT: Simulations Plus, Inc. Investors may have been Affected by Fraud -- Contact BFA Law about its Investigation

    globenewswire.com

    2025-09-26 08:07:00

    NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws.

    https://images.financialmodelingprep.com/news/simulations-plus-slp-alert-bragar-eagel-squire-pc-continues-20250925.jpeg
    SIMULATIONS PLUS (SLP) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Simulations Plus, Inc. on Behalf of Simulations Plus Stockholders and Encourages Investors to Contact the Firm

    globenewswire.com

    2025-09-25 17:16:00

    Simulations Plus Q3 miss, $67.3M loss, $77.2M impairment, cut guidance; announced restructuring. Shares fell $4.50, or 25.8%, to $12.97 on Jul 15, 2025.

    https://images.financialmodelingprep.com/news/simulations-plus-slp-faces-investor-scrutiny-after-asset-impairment-20250925.jpeg
    Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman

    globenewswire.com

    2025-09-25 14:21:00

    SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Hagens Berman has launched an investigation into Simulations Plus, Inc. (NASDAQ: SLP) after the company's stock price plummeted approximately 25% on July 15, 2025. This sharp decline followed a series of alarming disclosures, including a massive asset impairment charge and the abrupt termination of its newly hired independent auditor, Grant Thornton.

    https://images.financialmodelingprep.com/news/rosen-law-firm-encourages-simulations-plus-inc-investors-to-20250924.jpg
    Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

    prnewswire.com

    2025-09-24 17:12:00

    NEW YORK , Sept. 24, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

    https://images.financialmodelingprep.com/news/slp-investor-alert-simulations-plus-inc-is-being-investigated-20250924.png
    SLP INVESTOR ALERT: Simulations Plus, Inc. is Being Investigated for Securities Fraud after Impairment Charge Leads to 26% Stock Drop – Investors Urged to Contact BFA

    globenewswire.com

    2025-09-24 08:46:00

    NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws.

    https://images.financialmodelingprep.com/news/slp-investor-news-if-you-have-suffered-losses-in-20250923.jpg
    SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

    globenewswire.com

    2025-09-23 17:38:00

    NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.